Healthequity, INC 8-K filings

HealthEquity stockholders approved all five proposals at the 2026 Annual Meeting, including director elections and executive compensation.

HealthEquity reported strong Q1 2027 financial results, featuring a 29% increase in net income and an increased fiscal year outlook.

HealthEquity, Inc. has amended employment agreements for key executives to enhance severance benefits and modify equity vesting terms.

HealthEquity announced the termination of its Chief Technology Officer, Eli Rosner, effective April 17, 2026, with EVP Sunil Rajasekar to assume technology oversight.

HealthEquity announced record revenue and earnings for fiscal year 2026 and the fourth quarter, leading to a raised fiscal 2027 outlook.

HealthEquity, Inc. announced its initial fiscal year 2027 outlook, projecting revenues between $1.38 billion and $1.41 billion, while reaffirming its fiscal year 2026 guidance.

HealthEquity, a leader in health savings accounts, announced record third-quarter fiscal 2026 financial results, driven by strong revenue growth and significant increases in net income and Adjusted EBITDA.

HealthEquity, Inc. announced robust second-quarter fiscal year 2026 financial results, featuring significant revenue and profit growth, alongside an increase in HSA assets and accounts.

HealthEquity, Inc. announced that its stockholders approved all three proposals at the 2025 Annual Meeting, including the election of nine directors and the ratification of its auditor, while the Board of Directors authorized a new $300 million common stock repurchase program.

HealthEquity, Inc. announced strong first quarter fiscal year 2026 financial results, including record revenue and Adjusted EBITDA, leading to an increase in its full-year fiscal 2026 guidance.

Paul Black resigned from HealthEquity's Board of Directors, leading to a reduction in the board's size.

HealthEquity announces a 20% increase in revenue for fiscal year 2025, reaching $1.20 billion, alongside significant growth in net income and adjusted EBITDA.

HealthEquity announces year-end sales metrics, including a 14% increase in HSAs and a 27% growth in HSA assets, while affirming its fiscal 2025 and 2026 outlook.

HealthEquity reports strong estimated year-end results, including record new Health Savings Accounts (HSAs) and significant asset growth.

HealthEquity announced strong third quarter results with record revenue, HSA growth, and increased total assets under management.

HealthEquity, Inc. has agreed to a $30 million settlement with Union Mesa 1, LLC, resolving a lawsuit related to a terminated lease from April 2021.

HealthEquity's CEO, Jon Kessler, will retire, and Scott Cutler will take over as the new CEO effective January 6, 2025.

HealthEquity reported a 23% increase in revenue and a 46% increase in adjusted EBITDA for the second quarter of fiscal year 2025, along with a new $300 million stock repurchase program.

HealthEquity, Inc. has entered into a new $1 billion senior secured revolving credit facility, refinancing its previous $511.9 million debt.

HealthEquity, Inc. reported a data breach stemming from a compromised partner account, potentially exposing personally identifiable and protected health information of some members.

HealthEquity, Inc. stockholders approved a new equity incentive plan and elected ten directors at their annual meeting on June 27, 2024.

HealthEquity's first quarter results show significant growth in revenue, net income, and HSA accounts, leading to an increased full-year outlook.

HealthEquity, Inc. has published its 2024 Corporate Social Responsibility Report, highlighting the company's commitment to social and environmental responsibility.

HealthEquity has completed the acquisition of Conduent's BenefitWallet HSA portfolio, adding over 616,000 members and $2.7 billion in HSA assets.

HealthEquity, Inc. announces that director Frank Corvino will not seek re-election at the 2024 Annual Meeting of Stockholders, reducing the board size to 10 members.

HealthEquity successfully completed the second of three planned transfers of Conduent's health savings account portfolio, adding 134,000 HSAs and $555 million in assets.

HealthEquity reported a strong fiscal year 2024 with record revenue of nearly $1 billion and a significant increase in adjusted EBITDA, while also announcing the acquisition of the BenefitWallet HSA portfolio.

HealthEquity successfully completed the first of three tranches of its acquisition of Conduent's HSA portfolio, bringing approximately 266,000 HSAs and $1.1 billion in assets under its management.

HealthEquity announced a 9% increase in HSAs to 8.7 million and a 14% growth in HSA assets to $25.2 billion as of January 31, 2024, along with updated financial guidance and details for its upcoming Investor Day.